Brief: Cullinan Oncology Reports Fourth Quarter And Full Year 2023 Results

Cullinan Therapeutics

14/03/2024 12:06

March 14 (Reuters) - Cullinan Oncology Inc  CGEM.O :
    * CULLINAN ONCOLOGY PROVIDES CORPORATE UPDATE AND REPORTS
FOURTH
QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS
    * CASH AND INVESTMENTS OF $468.3 MILLION AS OF DECEMBER 31,
2023
CONTINUES TO PROVIDE RUNWAY INTO SECOND HALF OF 2026
    * CULLINAN REMAINS ON TRACK TO REPORT ADDITIONAL SOLID TUMOR
DOSE
ESCALATION DATA FOR CLN-619 IN Q2 OF 2024
    * CULLINAN ONCOLOGY INC- QTRLY LOSS PER SHARE $0.54

Source text for Eikon:  ID:nGNX4kyyxn 
Further company coverage:  CGEM.O 

 ((Reuters.Briefs@thomsonreuters.com;))